摘要
通过克隆脑膜炎奈瑟氏菌NhhA基因GNA0992于原核表达载体pET-20b,在大肠杆菌BL21(DE3)中实现了可溶性表达,表达量约占菌体蛋白总量的20%。经初步纯化后免疫小鼠,对其免疫原性进行了初步分析。结果显示,经3次腹腔免疫,血清IgG滴度达到23186,同时杀菌力实验显示NhhA能诱导针对B群脑膜炎奈瑟氏菌的补体依赖的杀菌反应。证明了NhhA是一种良好的抗原,为疫苗开发的蛋白靶标筛选工作奠定了基础。
Neisseria meningitidis gene GNA0992 was cloned into the prokaryotic expression vector pET-20b,and soluble expressed in E.coli BL21 (DE3).Purified NhhA stimulated a significant antigen-specific humoral response following three intraperitoneal immunization,while bactericidal assay showed that NhhA can elicit antibodies capable of inducing bactericidal activity against group B N.meningitidis strains.The results indicate that NhhA is a good candidate for vaccine development.
出处
《中国生物工程杂志》
CAS
CSCD
北大核心
2010年第4期8-12,共5页
China Biotechnology
关键词
脑膜炎奈瑟氏菌
NhhA
原核表达
免疫原性
Neisseria meningitides NhhA Prokaryotic expression Immunological property